About
Lentiviral & retroviral vector specialist, Genezen, offers early process development, GMP vector production, analytical testing & assay development.
Areas of Focus
Categories
Contract ManufacturingContract ManufacturingContract ManufacturingBoston & New EnglandServices
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
0
As Collaborator
2
Total Enrollment
147,356
By Phase
PHASE3: 1
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT03662022Collaborator
Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar
PHASE3Completed
144,000 participants
Started: Jan 2, 2019 · Completed: Jan 17, 2023
NCT03303963Collaborator
DIAgnostics for Multidrug Resistant Tuberculosis in Africa
N/ACompleted
3,356 participants
Started: May 4, 2017 · Completed: Nov 30, 2022
Locations (1)
Headquarters
Lexington, MA, United States
Map
Loading map...